Background The poor physical health of people with mental illness is a multifaceted,
transdiagnostic, and global problem. People with mental illness have an increased risk of …

The role of nutrition in mental health is becoming increasingly acknowledged. Along with
dietary intake, nutrition can also be obtained from “nutrient supplements”, such as …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Abstract Treatment-resistant schizophrenia (TRS) will affect about one in three patients with
schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be …

With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

There is no established treatment for patients with clozapine-resistant schizophrenia (CRS).
Clozapine augmentation strategies with antipsychotics or others substances are effective in …

Background Evidence for the management of inadequate clinical response to clozapine in
treatment-resistant schizophrenia is sparse. Accordingly, an international initiative was …

Objectives To identify the risks and benefits of clozapine‑lithium co-prescription. Methods
Articles published in English or French were identified with a MEDLINE, Web of Sciences …

Psychotic disorders represent a relatively rare but serious comorbidity in epilepsy. Current
epidemiological studies are showing a point prevalence of 5.6% in unselected samples of …

Abstract About 40%-70% of the patients with treatment-resistant schizophrenia have a poor
response to adequate treatment with clozapine. The impact of clozapine-resistant …